Start-Up

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

Bruce Shook joined Intact Vascular in 2014 as President and CEO. A highly-experienced, medical device executive with more than 30 years of industry experience, Bruce was previously Co-founder, Director, President, and CEO of Neuronetics, which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression.

Previously, Shook was Co-founder, Director, President, and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders. Before that, he served as President of Abiomed, where he successfully obtained a PMA approval for the first, FDA-approved ventricular assist device. Bruce developed cardiac pacing and anti-arrhythmia products at Cordis Corporation as well.

Bruce holds advanced degrees in Biomedical Engineering from Columbia University and Business Administration from the MIT Sloan School of Management. He earned a B.S. degree in Chemical Engineering from Penn State University.

Interview Highlights with Bruce Shook

  • After a storied medtech career, the device that Bruce is most proud of.
  • The origin story for the Tack Endovascular System and how it’s different than current peripheral vascular stents.
  • Bruce’s transition from Cordis to Abiomed and what he learned both personally and professionally.
  • Why Bruce decided to pursue an MBA from MIT after his run with Abiomed.
  • How Bruce and his team at Neuron Therapeutics responded after their failed clinical trial.
  • The lessons Bruce learned while trying to gain insurance coverage and reimbursement for the TMS device with Neuronetics.
  • Bruce’s advice for other medtech entrepreneurs that need to raise money beyond the “friends and family” round.
  • Bruce’s favorite business book, the CEO he most admires, and the advice he’d give to his 25-year-old self.

Listen to the Interview with Bruce Shook

Read the Interview with Bruce Shook

Download a copy of the interview transcript right here.

You May Like These Articles

  • Recent
  • Featured
  • Related

Key Mistakes to Avoid in Early-Stage Medical Device Development: Interview with Bob Paulson, CEO of VentureMed

In this conversation with Bob Paulson, CEO of VentureMed, he shares his vast medtech expertise, including capital fundraising tips, keys to early-stage medical device product development, and best practices when it comes to clinical evidence and insurance reimbursement.

How to Take Your Medtech Idea from Zero to One: Interview with Dr. Scott Wolf, Founder of Aerin Medical

In this interview with Dr. Scott Wolf, Founder of Aerin Medical, we break down the advantages of cash-pay versus insurance reimbursement, and get his advice for would-be founders hoping to turn a great medical device idea into a real prototype.

How to Transition from a Consumer Product to a Medical Device: Interview with Rohan Dixit, CEO of Lief Therapeutics

In this interview with Rohan Dixit, CEO of Lief Therapeutics, we discuss product development, how he approaches clinical research, and why they initially launched their device as an over-the-counter consumer product.

The Importance of Understanding Clinical Trial Design as a Medtech CEO: Interview with Nadim Yared, CEO of CVRx

In this interview with Nadim Yared, CEO of CVRx, we discuss his journey with the company, including Nadim’s expertise on clinical trial strategy, startup funding, and working with FDA & CMS.

Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular

In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.

Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger

In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.

Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market

In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.

Key Mistakes to Avoid in Early-Stage Medical Device Development: Interview with Bob Paulson, CEO of VentureMed

In this conversation with Bob Paulson, CEO of VentureMed, he shares his vast medtech expertise, including capital fundraising tips, keys to early-stage medical device product development, and best practices when it comes to clinical evidence and insurance reimbursement.

How to Take Your Medtech Idea from Zero to One: Interview with Dr. Scott Wolf, Founder of Aerin Medical

In this interview with Dr. Scott Wolf, Founder of Aerin Medical, we break down the advantages of cash-pay versus insurance reimbursement, and get his advice for would-be founders hoping to turn a great medical device idea into a real prototype.

How to Transition from a Consumer Product to a Medical Device: Interview with Rohan Dixit, CEO of Lief Therapeutics

In this interview with Rohan Dixit, CEO of Lief Therapeutics, we discuss product development, how he approaches clinical research, and why they initially launched their device as an over-the-counter consumer product.

The Importance of Understanding Clinical Trial Design as a Medtech CEO: Interview with Nadim Yared, CEO of CVRx

In this interview with Nadim Yared, CEO of CVRx, we discuss his journey with the company, including Nadim’s expertise on clinical trial strategy, startup funding, and working with FDA & CMS.

Success! Your membership is now active.